News | August 20, 2014

Boston Scientific, Asahi Intecc Announce Joint Development, Manufacturing Programs

August 20, 2014 — Boston Scientific Corp. and Asahi Intecc have formalized plans to develop a new, differentiated fractional flow reserve (FFR) wire. The joint project focuses on creating a device intended to improve handling compared to existing FFR wires.

The FFR market is an emerging field in interventional cardiology that exceeds $250 million worldwide and is experiencing a double-digit growth rate. FFR-guided percutaneous coronary intervention (PCI) is cost-effective and also reduces one-year major adverse cardiac events (MACE) rates. The jointly developed FFR wire will be designed for use with the Boston Scientific Polaris multimodality imaging system.

The companies have also agreed to collaborate on key enhancements to the Boston Scientific RotaWire atherectomy guidewire. Asahi Intecc will provide components for the new RotaWire, which is designed by Boston Scientific to provide improved control and handling. The RotaWire is a unique 0.009-inch wire that is used within the Rotablator rotational atherectomy system to treat calcified lesions in coronary arteries.

The introduction of the components manufactured by Asahi Intecc to advance the RotaWire atherectomy guidewire is further evidence of the Boston Scientific commitment to improving products used in the treatment of complex coronary disease.

"We expect our collaboration with Asahi Intecc to help improve care for patients with coronary artery disease and strengthen our interventional cardiology portfolio," said Kevin Ballinger, president, Interventional Cardiology, Boston Scientific. "The Asahi Intecc expertise in guidewire technology is unparalleled. By leveraging the strengths of our technologies, we have the opportunity to create truly differentiated products."

"Boston Scientific has advanced sensor and atherectomy technologies. By combining these technologies with our expertise in wires and components, we believe the manipulability of these products will improve dramatically," said Masahiko Miyata, president and CEO, Asahi Intecc. "Through our collaboration with Boston Scientific, we are confident that we will be able to help improve outcomes for patients."

Asahi Intecc specializes in wire drawing, wire forming, torque transmission and coating processes for percutaneous transluminal coronary angiography (PTCA) guidewires.

Boston Scientific anticipates commercializing both specialty wires in 2015.

For more information: www.bostonscientific.com

Related Content

PinnacleHealth First in Pennsylvania to Implant Sentinel Cerebral Protection System
News | Embolic Protection Devices| August 23, 2017
PinnacleHealth is the first hospital in Pennsylvania and one of the first 10 in the country to introduce new technology...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Ra Medical Systems Granted Broad Patent for DABRA Catheter
News | Peripheral Artery Disease (PAD)| August 09, 2017
August 9, 2017 — Ra Medical Systems announced that the United States Patent and Trademark Office (USPTO) has granted
Roxwood Medical Announces Agreement With Abbott for U.S. Product Distribution
News | Catheters| August 09, 2017
Roxwood Medical Inc. recently announced it has entered into an exclusive agreement with Abbott for distribution of...
New Jersey Researcher Exploring New Stem Cell Therapies for Heart Attacks
News | Stem Cell Therapies| August 04, 2017
In petri dishes in her campus laboratory at New Jersey Institute of Technology, Alice Lee is developing colonies of...
Overlay Init